|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Investment in ZEN, at fair value (cost $17,830 and $18,053 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||
| Investment in ZEN | ||||||||||||||||
| Total investment in ZEN, at fair value (cost $17,830 and $18,053 as of June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities: | ||||||||||||||||
| Sponsor's Fee payable, related party | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets | ||||||||||||||||
| Paid-in-capital | ||||||||||||||||
| Accumulated net investment loss | ||||||||||||||||
| Accumulated net realized gain on investment in ZEN | ||||||||||||||||
| Accumulated net change in unrealized depreciation on investment in ZEN | ||||||||||||||||
| Shares issued, no par value (unlimited Shares authorized) | ||||||||||||||||
| Shares outstanding, no par value (unlimited Shares authorized) | ||||||||||||||||
| Principal Market NAV per Share | ||||||||||||||||
Loading...
